Results 351 to 360 of about 900,371 (377)
Some of the next articles are maybe not open access.
Emergency Medicine Clinics of North America, 2011
Atrial fibrillation (AF) results from the chaotic depolarization of atrial tissue and is the most common dysrhythmia diagnosed in United States (US) emergency departments. AF affects greater than 1% of the general population, with a peak prevalence of 10% in those greater than 80 years of age. By 2050, it is estimated that nearly 16 million US patients
Eric, Goralnick, Laura J, Bontempo
openaire +3 more sources
Atrial fibrillation (AF) results from the chaotic depolarization of atrial tissue and is the most common dysrhythmia diagnosed in United States (US) emergency departments. AF affects greater than 1% of the general population, with a peak prevalence of 10% in those greater than 80 years of age. By 2050, it is estimated that nearly 16 million US patients
Eric, Goralnick, Laura J, Bontempo
openaire +3 more sources
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
International Journal of Stroke, 2020Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060.
G. Lippi, F. Sanchis-Gomar, G. Cervellin
semanticscholar +1 more source
DeckerMed Medicine: Cardiovascular Medicine, 2004
Atrial fibrillation (AF) is an abnormal rhythm characterized by chaotic atrial electrical activity resulting in loss of atrial contraction, an irregular and unpredictable heart rate, and a tendency for thrombus formation. The prevalence of AF is estimated at 1 to 2%, but it’s likely higher than that because one-third of patients may have no symptoms ...
Gregory F. Michaud, Roy M. John
openaire +2 more sources
Atrial fibrillation (AF) is an abnormal rhythm characterized by chaotic atrial electrical activity resulting in loss of atrial contraction, an irregular and unpredictable heart rate, and a tendency for thrombus formation. The prevalence of AF is estimated at 1 to 2%, but it’s likely higher than that because one-third of patients may have no symptoms ...
Gregory F. Michaud, Roy M. John
openaire +2 more sources
The Lancet, 2012
The management of atrial fibrillation has evolved greatly in the past few years, and many areas have had substantial advances or developments. Recognition of the limitations of aspirin and the availability of new oral anticoagulant drugs that overcome the inherent drawbacks associated with warfarin will enable widespread application of effective ...
Lip, GYH, Tse, HF, Lane, DA
openaire +4 more sources
The management of atrial fibrillation has evolved greatly in the past few years, and many areas have had substantial advances or developments. Recognition of the limitations of aspirin and the availability of new oral anticoagulant drugs that overcome the inherent drawbacks associated with warfarin will enable widespread application of effective ...
Lip, GYH, Tse, HF, Lane, DA
openaire +4 more sources
Chest, 2010
BACKGROUND Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts.
G. Lip +4 more
semanticscholar +1 more source
BACKGROUND Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts.
G. Lip +4 more
semanticscholar +1 more source
Journal of the American Medical Association (JAMA), 2001
CONTEXT Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described.
A. Go +6 more
semanticscholar +1 more source
CONTEXT Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described.
A. Go +6 more
semanticscholar +1 more source
Current Treatment Options in Cardiovascular Medicine, 2000
Atrial fibrillation will present the most significant arrhythmia management challenge for clinicians in the new millennium, particularly as the percentage of elderly patients and longevity increase worldwide. The clinical manifestations of the arrhythmia are wide ranging: paroxysmal to permanent modes of occurrence and asymptomatic to severely ...
Peter R. Kowey +3 more
openaire +3 more sources
Atrial fibrillation will present the most significant arrhythmia management challenge for clinicians in the new millennium, particularly as the percentage of elderly patients and longevity increase worldwide. The clinical manifestations of the arrhythmia are wide ranging: paroxysmal to permanent modes of occurrence and asymptomatic to severely ...
Peter R. Kowey +3 more
openaire +3 more sources
Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)
Cardiovascular Electrophysiology, 2022The last three decades have been characterized by an exponential increase in knowledge and advances in the clinical management of atrial fibrillation.
K. Bizhanov +4 more
semanticscholar +1 more source
Annals of Internal Medicine, 2023
Evidence for diagnosis and treatment of atrial fibrillation (AF) has expanded substantially since 2017, when In the Clinic last considered this subject. Direct oral anticoagulants have become the predominant therapy for thromboembolic disease, and antidotes for these drugs are now available.
openaire +2 more sources
Evidence for diagnosis and treatment of atrial fibrillation (AF) has expanded substantially since 2017, when In the Clinic last considered this subject. Direct oral anticoagulants have become the predominant therapy for thromboembolic disease, and antidotes for these drugs are now available.
openaire +2 more sources
Circulation, 2023
499 The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. Correspondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd
V. Algalarrondo, F. Extramiana
semanticscholar +1 more source
499 The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. Correspondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd
V. Algalarrondo, F. Extramiana
semanticscholar +1 more source